Clinical Trials Directory

Trials / Unknown

UnknownNCT04896983

National Survey of Mental Health After COVID-19 Outbreak

National Survey of Mental Health in the Second Year After COVID-19 Outbreak: Multilevel Analysis of Individual and Societal Factors

Status
Unknown
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
University of Belgrade · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

The Serbian national survey - acronym CoV2Soul.RS - has been launched to document mental health (MH) status and understand needs of the population in relation to the prolonged global public health crisis. This cross-sectional study will collect a representative national sample (18-65 years) by multi-stage probabilistic household sampling method. Trained staff will conduct face-to-face diagnostic interviews (M.I.N.I.). Battery of self-report instruments will be used to measure quality of Life (QoL), level of distress, and associated protective and harmful psychological and societal factors. The investigators aim to assess prevalence rates of MH disorders and associated QoL in the nationally representative sample, to explore how MH conditions and QoL vary with respect to socio-demographic variables, personality, health status and traumatic events during pandemics, and to find how these relationships depend on societal factors characterising municipalities in which they live. Moreover, this study will address perception of pandemic consequences and associated distress in relation to personality and different types of possible mediators. The prevalence rates of MH disorders will be calculated as percentages of participants with a positive diagnosis. The hierarchical structure of the data will be analyzed using Multilevel Random Coefficient Modeling, CoV2Soul.RS will contribute to an international evidence base about prevalence rates of psychiatric conditions during different phases of the pandemic in different regions and will identify protective and harmful psychological and societal factors for MH and QoL.

Conditions

Timeline

Start date
2021-06-01
Primary completion
2021-11-01
Completion
2022-03-01
First posted
2021-05-21
Last updated
2021-07-01

Locations

3 sites across 1 country: Serbia

Source: ClinicalTrials.gov record NCT04896983. Inclusion in this directory is not an endorsement.